Navigation Links
CareFusion Names Robert Friel to Board of Directors

SAN DIEGO, June 26 /PRNewswire-FirstCall/ -- CareFusion Corporation, the company that will become public from the planned spinoff of Cardinal Health's clinical and medical products businesses, today announced that Robert Friel will serve on the company's board of directors following the completion of the spinoff.

Friel, 53, is chairman and chief executive officer of PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment. He joined PerkinElmer in 1999 and has served in a variety of roles including chief financial officer, chief operating officer and divisional president.

The company made the announcement in the third amendment to its Form 10 registration statement, filed today with the Securities and Exchange Commission (SEC).

Friel joins CareFusion board members announced on June 9, including David Schlotterbeck, 62, chairman and chief executive officer; Philip Francis, 61, executive chairman of PetSmart, Inc. and Cardinal Health director since 2006; Jacqueline Kosecoff, 59, chief executive officer of Prescription Solutions for UnitedHealth Group; J. Michael Losh, 63, retired chief financial officer of General Motors and Cardinal Health director since 1996; Gregory Lucier, 45, chairman and chief executive officer of Life Technologies; Edward Miller, M.D., 66, chief executive officer of Johns Hopkins Medicine; Michael O'Halleran, 58, senior executive vice president of Aon Corporation and Cardinal Health director since 1999; and Robert Wayman, 63, retired executive vice president and chief financial officer of Hewlett Packard. Francis, Losh and O'Halleran will leave the Cardinal Health board of directors upon completion of the planned spinoff.

About CareFusion Corporation

CareFusion Corporation is currently a wholly owned subsidiary of Cardinal Health (NYSE: CAH) and is expected to become a public company from the planned spinoff of Cardinal Health's clinical and medical products businesses. The global company, with annual revenues of approximately $3.8 billion(1), will serve the health care industry with products and services that help hospitals improve the safety and quality of health care. With a focus on breaking the cycle of harmful medication errors and reducing hospital-acquired infections, CareFusion develops market-leading technologies including Alaris(R) IV pumps, Pyxis(R) automated dispensing and patient identification systems, MedMined(TM) electronic infection surveillance service, AVEA and Pulmonetic Systems ventilation and respiratory products, Jaeger and SensorMedics pulmonary products, ChloraPrep(R) infection prevention products and V. Mueller(R) surgical instruments. CareFusion employs more than 15,000 people across its global operations. The company has applied to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN."

(1) Fiscal 2008 pro forma revenue, Amendment No. 3 to Form 10 Registration Statement filed on June 26, 2009.

Cautions Concerning Forward-Looking Statements

This news release contains forward-looking statements addressing the planned spinoff of Cardinal Health's clinical and medical products businesses as a separate company named CareFusion, which is dependent upon future events or developments and subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of any such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion's Form 10 and Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.

SOURCE Cardinal Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
2. CareFusion Names Edward Borkowski as Chief Financial Officer
3. CareFusion Corporation Files Form 10 Registration Statement
4. InPlace Medical Solutions(TM) Names Malaysias Atlas Merger SDN.BHD as Regional Agent
5. Cardiogenesis Corporation Names Paul J. McCormick Executive Chairman
6. Physician Wellness Services Names Alan Rosenstein, M.D., M.B.A. as Medical Director
7. AUA Foundation names the 2009 Astellas Rising Stars in Urology award winners
8. PHT Names VP to Lead Sales of A-Claim Payment Solution for Doctors, Hospitals
9. Arcadia HealthCare Names Former Walgreens Executive Charles Goodall as Vice President of DailyMed(TM) Pharmacy Operations
10. Arcadian Management Services Names CEO Robert Fahlman as Chairman of the Board
11. Health Care Service Corporation Names Carolyn H. Clift as Senior Vice President and First Chief Diversity Officer
Post Your Comments:
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: